Carl Icahn has raised his hostile offer for Lionsgate to $7 a share, a 17% increase.
Lionsgate and Carl Icahn are ramping up their battle for control of the minimajor, with both sides campaigning over Lionsgate's proposed "poison pill" provision.
Thanks to Carl Icahn, Lionsgate toppers Jon Feltheimer and Michael Burns find themselves in the spotlight these days.
Saban Capital Group is partnering with Lionsgate on a plan to expand Lionsgate's Tiger Gate pay TV business in Asia.
Lionsgate is urging its shareholders to enact a poison pill provision that would make it far more difficult for Carl Icahn's hostile takeover to succeed.
When Carl Icahn bumped up his investment in Lionsgate to 9% in October 2008, Lionsgate spokesman Peter Wilkes told a reporter, "We welcome his input, which is always very perceptive. He has a great…
Lionsgate's reportedly pulling the plug on its efforts to buy MGM, leaving only Time Warner Inc. and Access Industries as bidders for the beleagurered studio.
The battle between Lionsgate and Carl Icahn has entered the trench warfare stage with both sides blasting each other on a daily basis.
Lionsgate issued the following response to Icahn's open letter:
As the battle for control of Lionsgate heats up, Carl Icahn issued an "open letter" to Lionsgate co-chairman and CEO Jon Feltheimer on Wednesday morning
In rejecting Carl Icahn's hostile takeover bid, Lionsgate's toppers are making the case that the minimajor is poised for serious growth if allowed to continue on its path.